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Abstract: Aging-associated dermatological pigmentary diseases are associated with accumulation
of senescence cells and the disruption of basement membrane due to chronic ultraviolet radiation
(UVR) exposure. Our study is on the synergistic effect of the novel 300 µm needle-depth fractional
microneedling radiofrequency (FMR) treatment and conventional Q-switched ND:YAG laser on
aging-associated hyperpigmentation of the skin. The prospective controlled clinical trial of 25 Asian
women revealed significantly higher improvements not only on wrinkles, but also on hyperpig-
mentation. Additional ex vivo study revealed significant reduction of pro-melanogenic markers as
well as senescent keratinocytes, while increased expression of collagen type IV on the epidermal
basement membrane, after additional FMR treatment on UV-irradiated human tissues. These results
demonstrate that 300 µm needle-depth FMR might effectively remove senescent keratinocytes that
secrete pro-melanogenic markers, and repair disrupted basement membrane, therefore preventing
constant hyperpigmentation of the aged skin.
Keywords: lentigo; melasma; fractional microneedling radiofrequency; Nd:YAG laser; ultraviolet
B; senescence
1. Introduction
Human skin, unlike other organs, undergoes photoaging processes in addition to
natural aging, which ultimately leads to aging-associated pigmentary changes. The ac-
quired benign hyperpigmentation disorders associated with aging include a wide range of
diseases such as lentigo, melasma, and post-inflammatory hyperpigmentation (PIH) [1].
Among them, senile lentigo is caused by a chronic exposure to ultraviolet radiation (UVR),
resulting in a characteristic hyperpigmented basal epidermal layer [2]. Hyperpigmentation
in melasma, which is also affected by UVR, is frequently described as a manifestation of
skin cellular senescence and is attributed to a consequent decrease in the physiological regu-
lation of melanogenic biosynthetic pathways [3]. One of the earliest signs of melasma in the
Asian population presents with mixed epidermal and dermal hyperpigmentation, showing
resistance to treatment with conventional lasers, such as Q-switched (QS) or long-pulsed
nanosecond neodymium-doped yttrium aluminum garnet (Nd:YAG) laser [3,4].
A recent meta-analysis on laser and laser compound therapy for melasma reported that
the two most commonly used treatment modalities for aging-associated facial pigmentation
until 2018 had been 1064 nm Nd:YAG and 1550 nm non-ablative fractional lasers [5]. The
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QS lasers targeting the destruction of melanocytes, including 532 nm QS Nd:YAG (QSNY),
ruby, and alexandrite lasers, have been popular in treating not only melasma, but also senile
lentigo; however, frequent occurrences of PIH, appearing in 10–25% of the cases, were
reported post-treatment [6–8]. Meanwhile, Iranmanesh et al. [8] (2021) recently published a
review article on the efficacy of energy-based devices combination therapy for melasma and
stated that fractional microneedling radiofrequency (FMR) was a novel adjuvant treatment
for melasma treated with low-fluence QSNY laser.
Abnormalities in the extracellular matrix, basement membrane disruption, and an
increase in the vascularity and number of mast cells, in addition to epidermal pigmentation,
are frequently observed on histopathological analysis of melasma [9–12]. Kwon et al. [13]
(2019) demonstrated in their retrospective review that a combination therapy with FMR
showed a better efficacy in treating melasma than the conventional QSNY monotherapy.
The study emphasized that while black chromophore-targeting laser treatments could
produce considerable degrees of unwanted side effects, such as mottled hypopigmentation
and rebound hyperpigmentation, combination therapy with FMR reduced the incidence of
these side effects by stabilizing the activity of melanocytes and the function of basement
membrane [13]. The aim of this study was to investigate the efficacy of 300 µm needle-
depth FMR on aging-associated hyperpigmentation of the face via affecting epidermal
cellular senescence. We performed a prospective clinical trial on 25 Asian women to ob-
serve the synergistic effect of 300 µm needle-depth FMR and conventional laser toning
on aging-associated hyperpigmentation. An additional human ex vivo study was con-




Twenty-five Asian women with facial pigmentation due to photoaging were enrolled
in the present study. The mean age of the subjects was 51.4± 7.56 years (range, 39–63 years).
Among the patients, 14 had Fitzpatrick skin type III and 11 had Fitzpatrick skin type IV. In
addition, 11 patients had a single type of pigmentation, melasma, while 14 presented with
a mixed type of age-related hyperpigmentation, including melasma and senile lentigo.
2.2. Clinical Efficacy of Adjuvant FMR Treatment after QSNY for Aging-Associated Hyperpigmentation
The additive effect of FMR with QSNY on age-related hyperpigmentation was evalu-
ated both quantitatively and qualitatively, by measuring the melanin index, Hemi Melasma
Area and Severity index (hemi-MASI), Fitzpatrick wrinkle and elastosis scale, and Global
Aesthetic Improvement Scale (GAIS). The QSNY + FMR group showed a significantly
higher reduction in the melanin index during the study period than the QSNY group
(p = 0.039, Figures 1 and 2A). Multiple comparison post hoc analyses revealed that the
QSNY + FMR group showed a significantly lower melanin index at week 16 than the
QSNY group (p < 0.01). Irrespective of the treatment methods, a significant reduction in the
hemi-MASI was observed in both groups (p < 0.05). Nonetheless, the QSNY + FMR group
showed a significantly higher reduction in the hemi-MASI than the QSNY group at weeks
12 and 16 (p < 0.01, Figure 2B). In addition, the improvement in wrinkles was assessed, and
the QSNY + FMR group showed a significantly higher reduction in the Fitzpatrick Wrinkle
and Elastosis Scale than the QSNY group (p < 0.001, Figure 2C). Multiple comparison post
hoc analyses revealed that the QSNY + FMR group showed a significantly lower Fitzpatrick
Wrinkle and Elastosis Scale at weeks 8, 12, and 16 than the QSNY group (p < 0.01). Finally,
the global improvements evaluated by the blinded, independent investigators revealed a
significantly higher GAIS in the QSNY + FMR group than in the QSNY group (p < 0.05,
Figure 2D).
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Figure 2. Clinical efficacy of adjuvant FMR treatment after QSNY for aging-associated hyperpigmentation. Improvements 
on pigmentation were assessed both (A) quantitatively by the melanin index and (B) qualitatively by hemi-MASI. (C) 
Improvements on wrinkles were evaluated via the Fitzpatrick wrinkle and elastosis scale. (D) GAIS was assessed by the 
investigators on week 12. Post hoc analyses for multiple comparison after RM-ANOVA on melanin index and hemi-MASI 
were performed via Student’s t-test after assuming normality (Kolmogorov–Smirnov test, p > 0.05). Statistical analysis for 
multiple comparison on Fitzpatrick wrinkle scale and GAIS were performed via Mann–Whitney U test. * p < 0.05, ** p < 
0.01, respectively. 
2.3. Safety Profile 
Pain, post-treatment erythema, and crusting were well tolerated by all the patients 
who had undergone repeated sessions. Serious adverse effects, including scarring, tex-
tural changes, bleeding, and secondary infections, were not observed during any treat-
ment session or the follow-up period. The patients reported much less pain and erythema 
after QSNY + FMR (300 μm needle-depth) treatment compared with the degree of pain 
and erythema after conventional FMR alone. 
2.4. Effect of FMR Irradiation after UVB Exposure on Skin Pigmentation 
To further assess the effect of FMR on aging-associated hyperpigmentation, we de-
signed a human ex vivo study and irradiated the skin samples with UVB (Figure 3A). 
Fontana–Masson staining revealed a significant increase in basal epidermal pigmentation 
after UVR, while subsequent FMR treatments significantly decreased the degree of epi-
dermal pigmentation (p < 0.05, Figure 3B,C). Moreover, mRNA expression levels of mark-
ers of melanogenesis, such as microphthalmia-associated transcription factor (MITF), ty-
rosinase (TYR), and tyrosinase-related protein 1 (TRP-1), were significantly reduced after 
UVB + FMR treatment compared with those after UVB treatment alone, indicating a pos-
sible skin-lightening role of FMR on photoaged, pigmented skin (p < 0.005, Figure 3C). 
Figure 2. Clinical efficacy of adjuvant FMR treatment after QSNY for aging-associated hyperpigmentation. Improvements on
pigmentation were assessed both (A) quantitatively by the melanin index and (B) qualitatively by hemi-MASI. (C) Improvements
on wrinkl s were evaluated via the Fitzpatrick wrinkle and elastosis sc le. (D) GAIS was assessed by the investigators on
we k 12. Po t hoc analyses for multiple compa ison after RM-ANOVA on melanin index and h mi-MASI were performed via
Student’s t-test after assuming norm lity (Kolmogorov–Smirnov test, p > 0.05). Statistical analysis for multiple compari on n
Fitzpatrick wrinkle scale and GAIS were performed via Mann–Whitney U test. * p < 0.05, ** p < 0.01, respectively.
2.3. Safety Profile
Pain, post-treatment erythema, and crusting were well tolerated by all the patients
who had undergone r peated s ssions. Serious advers eff cts, including scarring, textural
c anges, bleeding, and secondary i fections, were not observed d ring any treatment
session or the follow-up period. The patients reported much less pain and erythema after
QSNY + FMR (300 µm needle-depth) treatme t compared wit the degree of pain and
erythema after conventional FMR alone.
2.4. Effect of FMR Irradiation after UVB Exposure on Skin Pigmentation
To further assess the effect of FMR n agi g-associated hyperpigmentation, we de-
signed a human ex vivo study and irradiated the skin samples with UVB (Figure 3A).
Fontana–Masson staining revealed a significant increase in basal epidermal pigmentation
after UVR, while subsequent FMR treatments significantly decreased the degree of epider-
mal pigmentation (p < 0.05, Figure 3B,C). Moreover, mRNA expression levels of markers of
melanogenesis, such as microphthalmia-associated transcription factor (MITF), tyrosinase
(TYR), and tyrosinase-related protein 1 (TRP-1), were significantly reduced after UVB +
FMR treatment compared with those after UVB treatment alone, indicating a possible
skin-lightening role of FMR on photoaged, pigmented skin (p < 0.005, Figure 3C).




Figure 3. Effect of FMR irradiation after UVB exposure on skin pigmentation. (A) Ex vivo human skin study schedule. (B) 
qRT-PCR results show decreased pro-melanogenesis markers, MITF, TYR, and TYRP-1, in UVB-irradiated skin after FMR. 
(C) Fontana–Masson staining and tyrosinase IHC staining show significant reduction of pigmented area% and the tyrosi-
nase activity of UVB-irradiated skin tissue after FMR. Statistical analyses were performed via Mann–Whitney U test. * p < 
0.05, ** p < 0.01, *** p < 0.005, respectively. 
2.5. UVB-Induced Premature Senescence of Epidermal Keratinocytes Rescued by FMR 
Irradiation 
To investigate the molecular mechanism by which 300 μm needle-depth FMR re-
sulted in skin lightening, we performed terminal deoxynucleotidyl transferase-mediated 
dUTP nick end-labeling (TUNEL) assay to analyze genomic instability and premature se-
nescence induced by UVR. Our ex vivo study demonstrated that the number of TUNEL-
positive epidermal cells increased after UVB irradiation, whereas subsequent FMR treat-
ment decreased their numbers (Figure 4, p < 0.005). Stress-induced premature senescence 
is a genetically controlled process, mediated by p16 and p21, depending on the cellular 
p53 status [14]. Additional quantitative reverse transcription–polymerase chain reaction 
(qRT–PCR) revealed that the mRNA expression levels of not only p16, p21, and p53, but 
also of matrix metalloproteinase (MMP)-2 and MMP-9 significantly increased after UVB 
exposure. These markers of cellular senescence concordantly decreased significantly after 
FMR irradiation (Figure 4, p < 0.05). 
Previous research has shown causal connection between DNA damage response 
(DDR) and stress-induced cellular senescence [15]. We further analyzed the levels of pro-
teins involved in DDR in UVB-irradiated human skin specimens, before and after the ad-
ditional treatment with FMR, by staining tissues with γ-H2AX (part of DNA repair foci). 
The UVB-irradiated skin specimen showed significantly increased γ-H2AX positivity in 
cytokeratin 14-positive epidermal keratinocytes compared with the control group, while 
the subsequent FMR irradiation reversed this process (Figure 5, p < 0.005). Hence, we hy-
pothesized that the decreased senescence signaling in the epidermis after FMR might have 
blocked melanogenesis in the basal melanocytes, thus augmenting skin lightening. 
Figure 3. ffect f ft r B exposure on skin pigmentation. (A) Ex ivo human skin study schedule.
(B) qRT-PCR results show d cr ased pro-melanogenesis markers, MI F, TYR, and TYRP-1, in UVB-irra iated skin after
FMR. (C) Fontana–Masso staining and tyrosinase IHC staining show sig ificant reduction of pigmented area% and the
tyrosinase activity of UVB-irradiated skin tissue after FMR. Statistical analyses were performed via Mann–Whitney U test.
* p < 0.05, ** p < 0.01, *** p < 0.005, respectively.
2.5. VB-Induced Premature Senescence of Epidermal Keratinocytes Rescued by FMR Irradiation
To investigate the molecular mechanism by which 300 µm needle-depth FMR resulted
in skin light ning, we perf rmed terminal deoxynucleotidyl transferase-mediated dUTP
nick nd-labelin (TUNEL) assay t analyz genomic instability and premature senescence
induced by UVR. Our ex vivo study demonstrated that the number of TUNEL-positive pi-
dermal lls incr ased after UVB irradiation, wher as subsequent FMR treatment decreased
their numbers (Figur 4, p < 0.005). Stress-induce prematur senescence is a genetically
controlled process, mediated by p16 and 21, depending o the cellular p53 status [14].
Additional quantitative reverse transcription–polymerase chain reaction (qRT–PCR) re-
vealed that the mRNA expression levels of not only p16, p21, and p53, but also of matrix
metalloproteinase (MMP)-2 and MMP-9 significantly increased after UVB exposure. These
markers of cellular senescence concordantly decreased significantly after FMR irradiation
(Figure 4, p < 0.05).
Previous research has shown causal connection between DNA damage response
(DDR) and stress-induced cellular senescence [15]. We further analyzed the levels of
proteins involved in DDR in UVB-irradiated human skin specimens, before and after the
additional treatment with FMR, by staining tissues with γ-H2AX (part of DNA repair foci).
The UVB-irradiated skin specimen showed significantly increased γ-H2AX positivity in
cytokeratin 14-positive epidermal keratinocytes compared with the control group, while
the subsequent FMR irradiation reversed this process (Figure 5, p < 0.005). Hence, we
hypothesized that the decreased senescence signaling in the epidermis after FMR might
have blocked melanogenesis in the basal melanocytes, thus augmenting skin lightening.
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Double im unofluorescence staining of cytokeratin 14 and γ-H2AX shows a significant reduction of DDR on UVB-irradiated
epidermal keratinocytes after FMR. Statistical analyses were performed via Mann–Whitney U test. *** p < 0.005.
2.6. Restored Expression of Collagen Type IV in the UV-Irradiated Bas l Membrane after FMR
Previous research has hown that he melasma tissue specimens have a disrupted
base ent e brane and reduced expres ion of type IV collagen [9]. Our ex vivo study
revealed decreased expres ion of collagen type IV after UVB irradiation; nonetheles ,
F R irradiation significantly restored the expression of collagen type IV in the basement
e brane ( i r , p .005). These results suggest t at the increased number of
senesc nt keratinocytes in the lower epidermis due to UVR leads to the disruption of
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basement membrane due to the secretion of proteases such as MMP-2 and MMP-9. This is
reversed by FMR irradiation that reduces the number of senescent cells.
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3. Discussion
Several dermatological pigmentary diseases are associated with the accumulation
of senescent cells in the skin. Recent studies on aging-associated hyperpigmentation
suggest that senescent fibroblasts influence epidermal melanocytes via cross-talk that
occurs through the damaged basement membrane [16,17]. The disruption of the basement
membrane can be partially due to the significantly upregulated expressions of MMP-2
and MMP-9 when the epidermal cells undergo cellular senescence due to chronic UVR
exposure [18]. Studies on the pathogenesis of melasma suggested that the increase in
MMP expression upon chronic sun exposure increased the permeability of the basement
membrane [12,19]. Interestingly, the rise in MMP-2 and reduction in collagen type IV,
which is the ajor component of the epider al base ent membrane, correlated with the
increase in the nu ber of melanocytes that protruded into the dermis in melasma [19].
st y by oon et al. [20] (2018) on senile lentigo demonstrated that the senescent
fi roblasts upregulate MITF and tyrosinase in melanocytes via the dysregulation f stromal
cell-d rived factor-1 (SDF-1) signali g. They also reveal d that the r storation of SDF-1
signaling after the conventional ne dle-depth FMR treatment was as ociated with skin
li t . It is known that multiple types of cells of the skin, inclu ing dermal
fibroblasts, pidermal keratinocytes, and melanocytes, drive skin pigmentation during the
process of cellular sen s nce. Among them, keratinocytes are the main type of cells hat
are in olved in the nitiati n of melanogenesis in the skin. Due to chronic UVR exposur ,
senescent keratinocytes secrete α-melanocyte sti ulati ( )- , and
st cel factor in a p53-proopiomelanocortin (POMC)-depend t manner; the subsequent
activation of MITF then plays a critical role in the cascade involved in the induction f
melanogenesis [3,21–23].
ti , randomized split-face clinical study of 25 women with aging-
associated facial hyperpigmentation revealed that 300 µm n edle-depth FMR treatment
after conventional QSNY laser resulted in a synergistic effect on skin li te i . ared
ith the S onotherapy, ad itional treat ent ith 300 µ F after S laser
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toning resulted in significantly higher improvement in not only the wrinkle assessment
(Fitzpatrick wrinkle and elastosis scale), but also in quantitative (melanin index) and qual-
itative (hemi-MASI) pigmentation assessments. The overall GAIS score was also higher
in the QSNY + FMR group. FMR is currently being used for multiple indications, such as
wrinkles and skin tightening, acne scars, stretch marks, hair thinning, and rosacea/post-
inflammatory erythema [24]. Our study shows that non-insulated FMR with the novel
300 µm needle-depth approach can affectively target the epidermal basement membrane
with minimal pain, which can lead to skin lightening. Our ex vivo study results correlated
with the clinical findings, showing reduced basal pigmentation on Fontana–Masson stain-
ing as well as decreased mRNA expressions of pro-melanogenic markers (MITF, TYR, and
TRP-1) after UVB + FMR exposure compared with UVB exposure alone.
The mechanism of clinically significant synergistic effect on the reduction of aging-
associated pigmentation with 300 µm needle-depth FMR needs further investigation.
Cui et al. (2007) had shown that UV induction of POMC/MSH in skin is directly controlled
by p53 [25]. Another study showed that the administration of p53 inhibitor suppressed
the expressions of paracrine cytokines, SCF and ET-1, as well as melanogenic factors
such as KIT, ETR, melanocortin 1 receptor (MC1R), MITF, and tyrosinase, resulting in
inhibition of hyperpigmentation [26]. Our ex vivo study results suggested that the FMR
treatment of human skin tissue effectively reduced the numbers of TUNEL- and γ-H2AX-
positive keratinocytes in the epidermis. The mRNA expression of p16, p21, and p53, which
are the common markers of cellular senescence, also decreased significantly after FMR.
Subsequent analysis for MMP-2 and MMP-9 also showed a decrease in their levels of mRNA
expression, suggesting a possible role of 300 µm FMR in removing senescent keratinocytes
from the epidermis, thus preventing the initiation of p53-POMC-MITF dependent cascade
of melanogenesis.
Moreover, previous studies had shown decreased expression of collagen type IV in
human melasma tissues [12]. In this study, the immunofluorescence staining before and
after the FMR treatment of UVB-irradiated human skin showed significantly increased
linear expression of collagen type IV in the basement membrane compared with its expres-
sion in the UVB-irradiated tissues that had not undergone FMR. This suggests that 300 µm
needle-depth FMR may have a role not only in removing senescent keratinocytes that are
pro-melanogenic, but also in repairing the basement membrane disruption of photoaged
skin, preventing the constant hyperpigmentation due to the fall of melanin into the dermis.
The limitations of our studies include the relatively small number of the sample
size and the follow-up period. Moreover, there are multiple local factors other than
p53-induced melanogenesis regarding UVR-induced aging-associated hyperpigmentation.
Not only melanocortin/MC1R complex, but also other important regulators of melanin
pigmentation, including ETs, histamine, eicosanoids, and SCF, interact with cell surface
receptors to cause melanogenesis [27]. UVB also enhance the levels of corticotropin-
releasing hormone, endorphin, adrenocorticotropic hormone, sex steroids, and vitamin D,
thereby modifying cutaneous pigmentation [28,29]. Lastly, the p53-POMC axis discussed
in this study also requires additional confirmation, as other previous studies mention its
weakness with the experimental design, in particular with the use of C57BL6 mice of which
the melanin pigmentation occurs independently from POMC expression [30,31]. Further
in vitro studies are needed to confirm the ex vivo and clinical findings, and to provide a
complete understanding of senescence-associated hyperpigmentation of the skin.
4. Materials and Methods
4.1. Clinical Study Design and Patients
We conducted a prospective, split-face, randomized, single-blinded clinical trial on
25 Asian women with aging-associated hyperpigmentation (i.e., melasma, senile lentigo,
or mixed type) to evaluate the additive efficacy of FMR in reduction of facial pigmenta-
tion when combined with conventional 1064 nm Nd:YAG laser toning (QSNY + FMR vs.
QSNY alone). Adult patients aged older than 30 years with Fitzpatrick skin types III to
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IV who presented to Severance Hospital at Yonsei University for the treatment of facial
pigmentation diseases were enrolled. Exclusion criteria included history of keloid scarring,
photosensitivity, uncontrolled medical illness, pregnancy, previous laser/light-based treat-
ments, and use of cosmetics containing growth-factor-related constituents or bleaching
agents during the last 6 months. The clinical trial was approved by the Institutional Review
Board of Severance Hospital, Yonsei University (IRB No. 1-2020-0023, 5 Jun 2020). The
protocol was initiated following written informed consent in adherence to the principles of
Declaration of Helsinki.
4.2. Treatment Protocol
A dual-wave mode (pulsed/continuous) FMR equipped with non-insulated micronee-
dles arranged in a 5 × 5 array (Sylfirm XTM; Viol Co., Ltd., Seongnam, Korea) and a 1064
nm QSNY laser (MedLite C6TM; HOYA ConBio Inc., Fremont, CA, USA) were used in
this study. All laser treatments were performed by a single experienced dermatologist
(YIL). After gentle cleansing of the skin, a topical anesthetic (2.5% lidocaine HCl and 2.5%
prilocaine cream) was applied 30 min before laser treatment. The 1064 nm QSNY was
delivered with a fluence ranging from 2.5 to 3.5 J/cm2, spot size of 6 mm, and a repetition
rate of 10 Hz for three overlapping passes. Consecutively, FMR was performed using the
pulsed-wave mode (PW2), 300 µm microneedle-depth, and a power level ranging from
4 to 6 for two passes on one side of the face, chosen randomly by the investigator before
the laser treatment. Two treatment sessions were performed each week for a total of five
weeks for each patient (weeks 0, 2, 4, 6, and 8).
4.3. Efficacy Evaluation
Standard clinical photographs were taken at baseline and before each treatment with
a digital camera (Canon EOS 800D, Canon Inc., Tokyo, Japan) and were evaluated using a
specialized digital photography analyzer (Mark VuTM, PSI Plus, Suwon-si, Gyeonggi-do,
Korea). In addition, the melanin index was measured using Mexameter® MX 18 (Courage +
Khazaka Electronic GmbH, Köln, Germany). Improvements in pigmentation and wrinkles
were evaluated using the hemi-MASI score and 9-point Fitzpatrick Wrinkle and Elastosis
Scale, respectively, as previously described [22,23]. Each measurement was taken at baseline
and at weeks 4, 8, 12, and 16. After the end of the treatment period (10 sessions in total), all
patients were followed up for 8 weeks for the evaluation of long-term safety and efficacy
of the laser treatment. Three blinded investigators (JHL, JMK, JK) independently graded
the QSNY + FMR and QSNY side of each patient using the GAIS at the end of the study by
comparing clinical photographs taken at baseline and week 12.
4.4. Safety Evaluation
On each visit to the dermatology department, we performed detailed physical ex-
amination for each patient to assess the safety of the procedures. In addition, patient
reports regarding the type and severity of adverse events (e.g., hyper- or hypopigmen-
tation, pin-point bleeding, bruising, and scarring) after laser treatments were carefully
documented.
4.5. Ex Vivo Skin Organ Culture and UVB/FMR Irradiation Protocol
Residual normal human skin specimens that were left behind during free transverse
rectus abdominis myocutaneous flap breast reconstruction surgery were obtained from
the Department of Plastic Surgery, after approval from the Institutional Review Board
of Severance Hospital (IRB No. 4-2021-0262). Tissue specimens were divided into three
groups: control, UVB, and UVB + FMR group. Tissues that were going to be exposed to
UVR were cut into 2 × 2 cm2 pieces and irradiated twice using UVB lamps (G8T5E, Sankyo
Denki, Kanagawa, Japan) emitting 306 nm radiations at a dose of 300 mJ/cm2 and power
of 8 W, for 2 consecutive days. For the UVB + FMR group, UVB-exposed specimens were
incubated for 24 h and irradiated with Sylfirm XTM, at 300 µm microneedle-depth, PW2
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mode, and power level 4. The specimens were then cultured for 48 h and were harvested
for preparation. All tissues, including those in the control group, were cultured for a total
of 5 days. All experiments were repeated 3 times, independently.
4.6. Immunohistochemistry and Immunofluorescence
Melanin pigments were detected with a Fontana–Masson stain kit (ab150669, Abcam,
Cambridge, MA, USA). An image analysis was performed using Image J software (version
1.52a; National Institutes of Health, Bethesda, MD, USA) to quantify the percentage of
pigmented area out of the total epidermal area (area %).
Immunohistochemistry was performed on formalin-fixed, paraffin-embedded skin
tissue sections (5 µm thick). Sections were boiled in EnV FLEX TRS High pH (50×)
(GV804-11-2, DACO, Carpinteria, CA, USA) for 30 min for antigen unmasking. Slides were
incubated with 3% H2O2 (7722-84-1, Junsei Chemical Co., Ltd., Tokyo, Japan) on ice for
10 min followed by blocking in 5% bovine serum albumin (BSAS 0.1, Bovogen Biologi-
cals, Williams, East Keilor, Australia) with blocking buffer for 1 h at room temperature.
After washing with tris-buffered saline with 0.1% Tween® 20 detergent (TBS-T) (BTT-9120,
Tech&Innovation, Chuncheon-si, gangwon-do, Korea), the sections were incubated with
primary antibodies against Tyrosinase (ab738, dilution, 1:50; Abcam) overnight at 4 ◦C. A
DAKO peroxidase/DAB detection kit (K5007, DAKO) was used for detection. Slides were
stained with Mayer’s hematoxylin (s3309, DAKO) to visualize the nuclei.
For Immunofluorescence, human skin cryosections (5 µm thick) were fixed for 30 min
at RT with 4% paraformaldehyde (BPP-9004, Tech&Innovation), rinsed with TBS-T (BTT-
9120, Tech&Innovation) and incubated with primary antibody: γH2AX (ab81299, dilution,
1:250; Abcam, Cambridge), cytokeratin14 (ab7800, dilution, 1:100; Abcam), and collagen
IV(ab6586, dilution, 1:1000; Abcam) overnight at 4 ◦C. Sections were washed and incubated
for 1 h at room temperature with Alexa Fluor-488-conjugated anti-mouse IgG antibody
(A11008, dilution, 1:1000, Thermo Fisher Scientific, Waltham, MA, USA) and Alexa Fluor-
555-conjugated anti-rabbit IgG antibody (A27039, dilution, 1:1000, Thermo Fisher Scientific).
After detection, the sample was washed with TBS-T and mounted using a VECTASHIELD
mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (H-1200-10, Vector
Laboratories Inc., Burlingame, CA, USA). All fluorescence images were observed with a
laser-scanning microscope (LSM 700, Carl Zeiss, Jena, Germany).
4.7. Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labeling Assay
Apoptotic cells in the skin explant tissue were detected using the in situ Cell Death
Detection Kit, Fluorescein (11684795910, Roche, Penzberg, Germany) according to the
manufacturer’s protocol. TUNEL assay was performed on cryosections (5 µm thick).
The coverslips were mounted with VECTASHIELD mounting medium containing DAPI.
The samples were observed with a laser-scanning microscope (LSM 700, Carl Zeiss, Jena,
Germany) and analyzed with LSM 5 image browser software (Carl Zeiss).
4.8. RNA Isolation and Quantitative Reverse Transcription–Polymerase Chain Reaction
Total RNA from the skin explants was extracted using the RNAiso Plus (9109, Takara
Bio, Kusatsu, Shiga Prefecture, Japan), according to the manufacturer’s instructions. RNA
was quantified using NanoDrop 2000 spectrophotometer (NanoDrop Technologies, Wilm-
ington, DE, USA). Complementary DNA (cDNA) was synthesized using the RNA to cDNA
EcoDry Premix Kit (Takara Bio). qRT–PCR was performed on the solution containing SYBR
Green Master Mix (4309155, Promega Co., Madison, WI, USA), and specific primer pairs
(Macrogen, Seoul, Korea) using the QuantStudio 3 Real-Time PCR System (Applied Biosys-
tems, Thermo Fisher Scientific) in 20 µL reactions. PCR primer sequences are provided
in Table 1. Cycling conditions were as follows: 95 ◦C for 10 min, followed by 40 cycles at
95 ◦C for 15 s, 60 ◦C for 20 s, and 72 ◦C for 30 s. After performing qRT-PCR, the amount of
mRNA was calculated by the relative quantification method. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, Cell Signaling Technology, Danvers, MA, USA) was used as a
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housekeeping gene for normalization of the gene expression levels. The primer sequences
are proven as listed below.
Table 1. Primer lists.
Target Gene Primer Sequences (5′–3′)
MITF Forward: GGCTTGATGGATCCTGCTTTGCReverse: GAAGGTTGGCTGGACAGGAGTT
Tyrosinase Forward: GCACAGATGAGTACATGGGAGGReverse: CTGATGGCTGTTGTACTCCTCC
TYRP-1 Forward: TCTCAATGGCGAGTGGTCTGTGReverse: CCTGTGGTTCAGGAAGACGTTG
p16 Forward: CTCGTGCTGATGCTACTGAGGAReverse: GGTCGGCGCAGTTGGGCTCC
p21 Forward: AGGTGGACCTGGAGACTCTCAGReverse: TCCTCTTGGAGAAGATCAGCCG
p53 Forward: CCTCAGCATCTTATCCGAGTGGReverse: TGGATGGTGGTACAGTCAGAGC
MMP-2 Forward: AGCGAGTGGATGCCGCCTTTAAReverse: CATTCCAGGCATCTGCGATGAG
MMP-9 Forward: GCCACTACTGTGCCTTTGAGTCReverse: CCCTCAGAGAATCGCCAGTACT
GAPDH Forward: TGAGGTCACGGACGATTACTReverse: GTAGGCCCACGAAACAAATGAT
4.9. Western Blot Analysis
The tissue samples were washed twice with cold phosphate-buffered saline and
homogenized using a mechanical TissueLyser II (Qiagen, Hilden, Germany) with stainless
steel beads at 30 Hz for 2 min. Total protein was lysed with radioimmunoprecipitation
assay lysis buffer (RC2002, Biosesang, Seongnam-si, Gyeonggi-do, Korea), containing 1%
protease inhibitor cocktail (PPI 1015, Quartett, Berlin, Germany), and protein concentrations
were quantified using a bicinchoninic acid protein assay (B9643-1L, Sigma-Aldrich). Equal
amounts (20 µg) of protein for each sample were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (6–12% gradient gel) and transferred to nitrocellulose
membranes. Membranes were blocked with 5% skim milk (#232100, BD Biosciences, Seoul,
Korea) at room temperature for 1 h and then probed overnight at 4 ◦C with the primary
antibodies against collagen IV (ab6586, dilution, 1:1000; Abcam) and GAPDH (2118S,
dilution, 1:1000; Cell Signaling Technology), followed by treatment with anti-rabbit IgG
secondary antibody (7074S, dilution, 1:2000; Cell Signaling Technology) for 1 h at room
temperature. The protein bands were treated with enhanced chemiluminescent detection
reagent (LF-QC0101, Ab Frontier, Seoul, Korea). ImageQuant LAS-4000 Mini luminescence
image analyzer (LAS-4000, Fujifilm Life Sciences, Tokyo, Japan) was used to expose the
chemiluminescent samples and capture digital images, which were analyzed using ImageJ
software (National Institutes of Health, Bethesda, MD, USA).
4.10. Statistical Analyses
Data are presented as numbers (percentages) or means ± standard deviations. Data
sets were probed for normality using Kolmogorov–Smirnov test. Repeated-measures
analysis of variance and subsequent post hoc analysis by Student’s t-test or Mann–Whitney
U test was performed with Bonferroni’s correction to account for multiple comparisons.
For non-parametric independent variables, including the datasets from the ex vivo study,
data are presented as median + interquartile range, and Mann–Whitney U test was used
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for data analysis. A p-value < 0.05 was considered significant. All statistical analyses were
performed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA).
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